{"SPADE_UN_28326": {"Sequence Information": {"Peptide Name": "HBD-3 (22-45) [C33,41Del], Phd-3", "Sequence": "SCLPKEEQIGKSTRGRKCRRKK", "Sequence Length": 22, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P81534", "uniprotUrl": "http://www.uniprot.org/uniprot/P81534", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins.", "Pubmed ID": "24086767", "Reference": "PLoS One. 2013;8:e77031", "Author": "Olli S, Rangaraj N, Nagaraj R", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/24086767"}, {"Title": "Antibacterial activities of synthetic peptides corresponding to the carboxy-terminal region of human beta-defensins 1-3.", "Pubmed ID": "16860904", "Reference": "Peptides. 2006;27:2607-2613", "Author": "Krishnakumari V, Singh S, Nagaraj R", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/16860904"}, {"Title": "Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3.", "Pubmed ID": "18809937", "Reference": "Antimicrob Agents Chemother. 2009;53:256-260", "Author": "Krishnakumari V, Rangaraj N, Nagaraj R", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/18809937"}, {"Title": "Human-?-defensins-1-3 and analogs do not require proton motive force for antibacterial activity against Escherichia coli.", "Pubmed ID": "23980689", "Reference": "FEMS Microbiol Lett. 2013;348:52-57", "Author": "Krishnakumari V, Packiyanathan KK, Nagaraj R", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/23980689"}, {"Title": "Effects of increasing hydrophobicity by N-terminal myristoylation on the antibacterial and hemolytic activities of the C-terminal cationic segments of human-?-defensins 1-3.", "Pubmed ID": "29682907", "Reference": "Chem Biol Drug Des. 2018;:", "Author": "Viswanatha K, Guru A, Adicherla H, Ramakrishnan N", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29682907"}], "Mass": 2589.05, "PI": 10.56, "Net Charge": 7, "Hydrophobicity": -1.79, "Frequent Amino Acids": "KRC", "Absent Amino Acids": "ADFHMNOUVWY", "Basic Residues": 9, "Acidic Residues": 2, "Hydrophobic Residues": 4, "Polar Residues": 18, "Positive Residues": 9, "Negative Residues": 2, "SPADE ID": "SPADE_UN_28326", "Similar Sequences": [{"SPADE_ID": "SPADE_N_03155", "Similarity": 1.0, "Sequence": "GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK"}, {"SPADE_ID": "SPADE_N_03971", "Similarity": 1.0, "Sequence": "LQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK"}, {"SPADE_ID": "SPADE_N_04007", "Similarity": 1.0, "Sequence": "YYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK"}], "Hemolytic Activity": "Rat erythrocytes:-=NA", "Target Organism": "Escherichia coli MG1655(LC=17µM),Staphylococcus aureus ATCC 8530(LC=17µM),Candida albicans(MFC=16µM),Escherichia coli W160-37(LC=17µM),Staphylococcus aureus NCTC 8530(LC=17µM),Escherichia coli MG1655(no activity data),Escherichia coli MG1655(no activity data),Escherichia coli ftsEX(LC=16µM),Staphylococcus aureus NCTC 8530(no activity data)"}}}